Mirtazapine-Associated Nocturia in a 56-Year-Old Diabetic Patient – Case Report

The Korean Pharmaceutical Association’s adverse‑event report highlights a specific case submitted to the regional drug‑safety center. The patient is a 56‑year‑old woman with a history of diabetes (details unspecified) and insulin‑related neuropathy. In July 2026 she experienced nocturia, which was suspected to be linked to mirtazapine therapy. She was concurrently taking a fixed‑dose combination of metformin and sitagliptin, as well as eszopiclone and escitalopram. The report notes that the patient suffered from insomnia, affecting daily life, and was prescribed mirtazapine 7 mg (dosage truncated in the source). The case is presented to provide expert evaluation and practical insight for clinicians handling similar adverse events.